Clinical Trial Update: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV

View source ↗

Summary

A pediatric clinical trial is assessing the therapeutic efficacy of anti-CD19 CAR-T cells in children with refractory ANCA-associated vasculitis and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Anti-CD19 CAR T cells (CD19-directed CAR T cells)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: ANCA Associated Vasculitis, CAR-T Cell Therapy | Status: RECRUITING